Cargando…

Mitochondrial protein, TBRG4, modulates KSHV and EBV reactivation from latency

Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr (EBV) are gammaherpesviruses associated with multiple human malignancies. KSHV is the etiological agent of Kaposi’s Sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD). EBV is associated with Burkitt’s ly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huirong, Wong, Jason P., Ni, Guoxin, Cano, Patricio, Dittmer, Dirk P., Damania, Blossom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683600/ https://www.ncbi.nlm.nih.gov/pubmed/36417478 http://dx.doi.org/10.1371/journal.ppat.1010990

Ejemplares similares

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway
por: Zhang, Huirong, et al.
Publicado: (2020)

Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency
por: Broussard, Grant, et al.
Publicado: (2023)

NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency
por: Ma, Zhe, et al.
Publicado: (2017)

KSHV: Immune Modulation and Immunotherapy
por: Broussard, Grant, et al.
Publicado: (2020)

Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency
por: Hopcraft, Sharon E., et al.
Publicado: (2018)

KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice
por: Sin, Sang-Hoon, et al.
Publicado: (2015)

The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
por: Jacobs, Sarah R., et al.
Publicado: (2011)

AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
por: Bhatt, Aadra P., et al.
Publicado: (2013)

KSHV LANA—The Master Regulator of KSHV Latency
por: Uppal, Timsy, et al.
Publicado: (2014)

Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies
por: Chugh, Pauline E., et al.
Publicado: (2013)

Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV
por: van Gent, Michiel, et al.
Publicado: (2021)

The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival
por: Anders, Penny M., et al.
Publicado: (2016)

The Prevalence of EBV and KSHV in Odontogenic Lesions
por: Alsaegh, Mohammed Amjed, et al.
Publicado: (2022)

Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
por: Wen, Kwun Wah, et al.
Publicado: (2010)

Contribution of the KSHV and EBV lytic cycles to tumourigenesis
por: Manners, Oliver, et al.
Publicado: (2018)

EBV Reactivation from Latency Is a Degrading Experience for the Host
por: Casco, Alejandro, et al.
Publicado: (2023)

Macrophages drive KSHV B cell latency
por: Szymula, Agnieszka, et al.
Publicado: (2023)

Electron microscopy mapping of the DNA-binding sites of monomeric, dimeric, and multimeric KSHV RTA protein
por: Calhoun, Jayla C., et al.
Publicado: (2023)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
por: Gam ze Letova, Chen, et al.
Publicado: (2021)

KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA
por: Cheng, Fang, et al.
Publicado: (2009)

cGAS and STING: At the intersection of DNA and RNA virus-sensing networks
por: Ni, Guoxin, et al.
Publicado: (2018)

Development of a proteomic platform for EBV and KSHV serological screening
por: Wang, Leyao, et al.
Publicado: (2010)

Emerging Themes from EBV and KSHV microRNA Targets
por: Ramalingam, Dhivya, et al.
Publicado: (2012)

Treatment of Kaposi Sarcoma-Associated Herpesvirus-Associated Cancers
por: Dittmer, Dirk P., et al.
Publicado: (2012)

The switch between EBV latency and replication.
por: Miller, G.
Publicado: (1989)

MLL1 is regulated by KSHV LANA and is important for virus latency
por: Tan, Min, et al.
Publicado: (2021)

Toll-Like Receptor-3 Is Dispensable for the Innate MicroRNA Response to West Nile Virus (WNV)
por: Chugh, Pauline E., et al.
Publicado: (2014)

Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV
por: Romeo, Maria Anele, et al.
Publicado: (2020)

PPP6C Negatively Regulates STING-Dependent Innate Immune Responses
por: Ni, Guoxin, et al.
Publicado: (2020)

Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation
por: Vladimirova, Olga, et al.
Publicado: (2021)

Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
por: Dittmer, Dirk P, et al.
Publicado: (2012)

Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas
por: Rivera-Soto, Ricardo, et al.
Publicado: (2021)

Nucleophosmin Phosphorylation by v-Cyclin-CDK6 Controls KSHV Latency
por: Sarek, Grzegorz, et al.
Publicado: (2010)

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
por: Bhatt, A, et al.
Publicado: (2009)

C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression
por: O’Farrell, Courtney, et al.
Publicado: (2010)

Profiling viral and host microRNA expression in cells infected with KSHV and EBV
por: Whitby, D, et al.
Publicado: (2009)

NEDDylation Is Essential for Kaposi’s Sarcoma-Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target
por: Hughes, David J., et al.
Publicado: (2015)

The Role of RNA Sensors in Regulating Innate Immunity to Gammaherpesviral Infections
por: Zhang, Huirong, et al.
Publicado: (2023)

High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi
por: Montgomery, Nathan D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uvp8r2tkdu540d0iko2feqigd3